A Multicenter, Open Label, Single Arm, Phase II Study to Investigate the Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Patients With Advanced Hepatocellular Carcinoma (HCC).
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2011
At a glance
- Drugs Gemcitabine; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2008 New trial record.